Orbimed Advisors LLC Kezar Life Sciences, Inc. Transaction History
Orbimed Advisors LLC
- $4.24 Billion
- Q3 2024
A detailed history of Orbimed Advisors LLC transactions in Kezar Life Sciences, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 1,927,000 shares of KZR stock, worth $12.4 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,927,000
Previous 1,927,000
-0.0%
Holding current value
$12.4 Million
Previous $1.16 Million
28.29%
% of portfolio
0.03%
Previous 0.03%
Shares
8 transactions
Others Institutions Holding KZR
# of Institutions
61Shares Held
38.4MCall Options Held
13.8KPut Options Held
600-
Suvretta Capital Management, LLC New York, NY7.17MShares$46.2 Million0.22% of portfolio
-
Avidity Partners Management LP Dallas, TX5.03MShares$32.4 Million0.24% of portfolio
-
Tang Capital Management LLC San Diego, CA3.64MShares$23.4 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.74MShares$17.7 Million0.0% of portfolio
-
Affinity Asset Advisors, LLC New York, NY2.51MShares$16.2 Million0.33% of portfolio
About Kezar Life Sciences, Inc.
- Ticker KZR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,369,504
- Market Cap $440M
- Description
- Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...